Stout Advises Healthmark Industries on Sale to Getinge AB

Stout announced today that its client, Healthmark Industries Company, Inc., has been acquired by Getinge AB for $320 million, representing a multiple of 17x estimated EBITDA for 2023. Getinge AB, founded in 1904 and based in Gothenburg, Sweden, is a leading global manufacturer of medical equipment and associated consumables used by hospitals for reprocessing and sterilization of surgical instruments and medical devices. It is also a leading manufacturer and marketer of equipment used in cardiac surgery, operating suites, and pharmaceutical production.

Founded in 1969 and based in Fraser, Michigan, Healthmark Industries is a leading manufacturer, marketer, and distributor of consumable medical devices and supplies used by sterile processing departments in hospitals for cleaning verification and sterile instrument packaging. In its fiscal year ending October 31, 2023, Healthmark expects revenue to increase 15% to $126 million.

Stout served as exclusive financial advisor to Healthmark in connection with this transaction.

Stout Managing Director John Calcagnini, who led the deal team, said, “The acquisition is expected to significantly enhance Getinge’s consumable offering to complement its sales of sterilization and reprocessing equipment, offering hospital customers a complete and best-in-class bundle of products and services designed to drive market share inroads.

“We also see an enormous opportunity for Getinge to expand distribution of Healthmark products to its’ international customers, as Healthmark generates 90% of revenue in the U.S. today. We don’t see why they could not grow the business to the point where international represents 50% of the mix, which is what we see with other large medical device manufacturers.”

Mark Basile, CEO of Healthmark, said, “We chose Stout for their expertise in medical devices and track record in managing cross-border transactions like ours, and that proved to be a great call. We would like to thank them for their leadership, efficiency, professionalism, knowledge, and excellent work in managing our process and putting together this important transaction. Stout’s assistance was irreplaceable, particularly in putting the finer points of the deal together and helping to map out the synergies. At the end of the day, Stout helped bring excellent value to the shareholders of Healthmark.”

Stout’s Eric Froidevaux, Max Halsted, Jake Kussin-Bordo, and Nate Lombard assisted in executing the deal.

Howard & Howard served as legal counsel to Healthmark. Covington and Burling LLP acted as legal counsel to Getinge AB.

SourceSTOUT
Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

he Intracept system, a basivertebral nerve ablation therapy, will be an addition to the Boston Scientific chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure.
"As Probo Medical has grown, we've seen the value of tailoring our commercial offering to the specific needs of specialists that we serve. Davis Medical provides us with exactly that in the cardiology specialty, with decades of experience and a refined approach to support cardiology practices with the equipment, services and supplies they need to run their practice," said Michael Asmer, CEO of Probo. "Additionally, the Davis Medical team adds significant strength to our footprint in the western US."
“This acquisition will provide a much-needed treatment to patients in need,” said Orlaith Ryan, chief technical officer and co-founder of Shorla Oncology. “It brings a crucial oral treatment to a larger patient population who suffer from cancer and other debilitating illnesses.”
Paragon Medical serves a wide range of specialty applications including orthopedics, minimally invasive surgery, robotic surgery, and drug delivery. Paragon's product portfolio includes single-use and consumable surgical instruments and implantable components sold to a diverse blue-chip customer base of leading medical device manufacturers.
“Time is of the essence during medical emergencies, as we saw in 2022 when EU member states required emergency shipments of Tecovirimat SIGA to treat patients infected with mpox,” said Meridian Medical Technologgies Commercial Head – Injectables & Health Security, Tom Handel. “This joint procurement framework contract, a significant milestone for both Meridian and HERA, reduces the time and effort required to put individual contracts in place with each member state from months to days. There are now multiple paths in Europe for streamlined procurement, allowing member state agencies to get much needed medical countermeasures into the hands of those in need.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy